Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask The Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
PR Newswire
Report Store
UsernamePublicRestriction
Brought to you by

Inverness buys 76% of Standard Diagnostics for KRW242bn

Feb 2010

Executive Summary

Inverness Medical Innovations has agreed to acquire 75.79% of public South Korean firm Standard Diagnostics for approximately KRW242bn ($215.6mm) in cash, or KRW40k per share.
Deal Industry
  • In Vitro Diagnostics
    • Biosensors
    • Chemistry, Immunoassay
    • Glucose Testing
    • Urine-based Testing
  • Medical Devices
    • Monitoring Equipment & Devices
  • Research, Analytical Equipment & Supplies
Deal Status
  • Final
Deal Type
  • Acquisition
    • Partial Acquisition
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By